4//SEC Filing
Wang Sheldon 4
Accession 0001567619-18-000122
CIK 0001561387other
Filed
Aug 7, 8:00 PM ET
Accepted
Aug 8, 4:20 PM ET
Size
17.9 KB
Accession
0001567619-18-000122
Insider Transaction Report
Form 4
Wang Sheldon
Chief Technology Officer
Transactions
- Exercise/Conversion
Class A Common Stock
2018-08-06$12.13/sh+5,107$61,948→ 38,782 total - Disposition to Issuer
Class A Common Stock
2018-08-06$43.75/sh−4,459$195,081→ 59,362 total - Exercise/Conversion
Class A Common Stock
2018-08-06$6.77/sh+5,039$34,114→ 63,821 total - Exercise/Conversion
Stock Appreciation Rights
2018-08-06−5,107→ 0 totalExercise: $12.13Exp: 2021-07-14→ Class A Common Stock (5,107 underlying) - Exercise/Conversion
Class A Common Stock
2018-08-06$4.95/sh+20,000$99,000→ 58,782 total - Sale
Class A Common Stock
2018-08-06$43.33/sh−6,593$285,687→ 52,769 total - Exercise/Conversion
Stock Appreciation Rights
2018-08-06−5,039→ 0 totalExercise: $6.77Exp: 2021-05-25→ Class A Common Stock (5,039 underlying) - Exercise/Conversion
Stock Appreciation Rights
2018-08-06−20,000→ 0 totalExercise: $4.95Exp: 2022-07-01→ Class A Common Stock (20,000 underlying)
Footnotes (5)
- [F1]Shares retained by the issuer to satisfy the exercise price of stock appreciation rights exercised by the reporting person.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.50 to $43.85, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth.
- [F3]These stock-settled stock appreciation rights were previously granted under the Plan and are scheduled to vest in increments of 20%, 20%, 20%, and 40% on successive anniversary dates of the grant, subject to the terms of the plan and an award agreement under the plan.
- [F4]These stock-settled stock appreciation rights were granted under the Issuer's Long Term Incentive Plan (the "Plan") and are vested as of the date of this Form 4.
- [F5]These stock-settled stock appreciation rights were previously granted under the Plan and are scheduled to vest in increments of 25%, 25%, and 50% on successive anniversary dates of the grant, subject to the terms of the Plan and an award agreement under the Plan.
Documents
Issuer
Health Insurance Innovations, Inc.
CIK 0001561387
Entity typeother
Related Parties
1- filerCIK 0001366008
Filing Metadata
- Form type
- 4
- Filed
- Aug 7, 8:00 PM ET
- Accepted
- Aug 8, 4:20 PM ET
- Size
- 17.9 KB